Cite
APA Citation
Kavan, P., Barrera, I., Azoulay, L., Martin, A., Vasilevsky, C., Boutros, M., Ferland, E., Batist, G., & Vuong, T. (n.d.). 494PA multi-institutional randomized phase II study on the timing of oxaliplatin plus 5-fluorouracil (FOLFOX) for patients (pts) with operable stage III rectal cancer: The KIR study. Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095324713.0x000035